Status:
COMPLETED
Melatonin Effects on Genital Herpes in Brazilian Women
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Genital Herpes
Eligibility:
FEMALE
15-49 years
Phase:
PHASE4
Brief Summary
Genital herpes is a common and increasingly-common infection worldwide. The annual incidence in the United States is 1.75 per 1000 inhabitants. The etiologic agent is the herpes type 1 and 2 strains s...
Detailed Description
The authors have investigate the relationship of estrogen-dependent malignant tumors with reduced levels of melatonin. It is speculated that the indoleamine can be classified as anti-estrogenic drug, ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- clinical and laboratory diagnosis of genital herpes
- real time polymerase chain reaction for herpes type 2
- serology
- Exclusion criteria:
- immunodeficiencies
- pregnant women
Exclusion
Key Trial Info
Start Date :
September 2 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03831165
Start Date
September 2 2015
End Date
December 28 2021
Last Update
January 11 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Avenida Doutor Eneas Carvalho de Aguiar 255 10 andar
São Paulo, São Paulo, Brazil, 05403000
2
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil, 05403000